Creatinine

Creatinine

SCHEMBL16295

CN1CC(=O)NC1=N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Creatinine SCHEMBL7203535 1.00
Creatinine SCHEMBL8809815 1.00 CRBN (0.61)
Creatinine SCHEMBL288087 1.00 CRBN (0.61)
Creatinine SCHEMBL4332495 0.98
Creatinine SCHEMBL3514057 0.98
Creatinine SCHEMBL435006 0.98
Creatinine SCHEMBL6473476 0.98
Creatinine SCHEMBL8637084 0.98
Creatinine SCHEMBL21404081 0.98
Creatinine SCHEMBL2922002 0.98

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 145435 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144923-A1 EXTRACORPOREAL BLOOD TREATMENT APPARATUS GAMBRO LUNDIA AB (SE) 2026-05-28 US claimed
US-20260148848-A1 BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2026-05-28 US claimed
US-20260148852-A1 ORGANIC MOLECULE EXPOSOMICS LINUS BIOTECHNOLOGY INC. (US) 2026-05-28 US claimed
EP-4747636-A2 TARGETED TREATMENT OF COMPLEMENT-MEDIATED DISEASE THROUGH LOCAL COMPLEMENT INHIBITION BASED ON URINARY UC5B-9 DETECTION Akebia Therapeutics Inc. (US) 2026-05-27 EP claimed
EP-4746887-A1 METHODS OF TREATING CHRONIC KIDNEY DISEASE (CKD) OR CKD AND HYPERTENSION WITH LORUNDROSTAT, OR A COMBINATION OF LORUNDROSTAT AND A SGLT2 INHIBITOR Mineralys Therapeutics, Inc. (US) 2026-05-27 EP claimed
EP-4223352-B1 DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS UROTRONIC INC (US) 2026-05-27 EP claimed
EP-4747607-A1 DEVICES AND METHODS FOR OPTICAL ANALYSIS OF BIOLOGICAL SAMPLES Vital Biosciences Inc. (CA) 2026-05-27 EP claimed
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
CN-119215059-B Application of dexserine phosphate in preparation of medicine for preventing and/or treating kidney injury LANZHOU UNIVERSITY (CN) 2026-05-26 CN claimed
CN-122094705-A PTH treatment for chronic kidney disease 2026-05-26 CN claimed
US-4087329-A CULTURING BREVIBACTERIUM, CORYNEBACTERIUM, PSEUDOMONAS, OR ARTHROBACTER KYOWA HAKKO KOGYO CO., LTD. (JA) 1978-05-02 US claimed
US-4064042-A SULFONATE STYRENE-DIVINYLBENZENE COPOLYMER ROHM AND HAAS COMPANY (US) 1977-12-20 US claimed
US-4044772-A Apparatus for cardiovascular conditioning and other physiological purposes SCHLOSS BENJAMIN 1977-08-30 US claimed
US-4042329-A Method and device for detecting cholesterol BECTON, DICKINSON AND COMPANY (US) 1977-08-16 US claimed
US-4039384-A Creatinine amidohydrolase and creatine amidinohydrolase and process for producing them NODA INSTITUTE FOR SCIENTIFIC RESEARCH (JA) 1977-08-02 US claimed
US-4022883-A UREA-CREATINE-CREATININE-URIC ACID DEGRADING BACTERIA BIOSCAL GMBH (DT) 1977-05-10 US claimed
US-3988483-A Liquid starch-urea ruminant feed and method of producing same THE KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 1976-10-26 US claimed
US-3979320-A Liquid crystal composition HODOGAYA CHEMICAL CO., LTD. (JA) 1976-09-07 US claimed
US-3964871-A GLUCOSE OXIDASE, HORSERADISH PEROXIDASE BECTON, DICKINSON AND COMPANY (US) 1976-06-22 US claimed
US-3934007-A DIOCTYL SODIUM SULFOSUCCINATE AND ACTIVATE CARBON, OXY-STARCH OR OXYCELLULOSE AMERICAN CYANAMID COMPANY (US) 1976-01-20 US claimed